These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

3377 related items for PubMed ID: 19626489

  • 1. Identification of rare anti-phospholipid/protein co-factor autoantibodies in patients with systemic lupus erythematosus.
    Szodoray P, Tarr T, Tumpek J, Kappelmayer J, Lakos G, Poor G, Szegedi G, Kiss E.
    Autoimmunity; 2009 Sep; 42(6):497-506. PubMed ID: 19626489
    [Abstract] [Full Text] [Related]

  • 2. The value of IgA antiphospholipid testing for diagnosis of antiphospholipid (Hughes) syndrome in systemic lupus erythematosus.
    Bertolaccini ML, Atsumi T, Escudero Contreras A, Khamashta MA, Hughes GR.
    J Rheumatol; 2001 Dec; 28(12):2637-43. PubMed ID: 11764209
    [Abstract] [Full Text] [Related]

  • 3. Antiphospholipid antibody tests: spreading the net.
    Bertolaccini ML, Gomez S, Pareja JF, Theodoridou A, Sanna G, Hughes GR, Khamashta MA.
    Ann Rheum Dis; 2005 Nov; 64(11):1639-43. PubMed ID: 15817655
    [Abstract] [Full Text] [Related]

  • 4. IgG reactivity to phospholipid-bound beta(2)-glycoprotein I is the main determinant of the fraction of lupus anticoagulant activity quenched by addition of hexagonal (II) phase phospholipid in patients with the clinical suspicion of antiphospholipid-antibody syndrome.
    Safa O, Crippa L, Della Valle P, Sabbadini MG, Viganò D'Angelo S, D'Angelo A.
    Haematologica; 1999 Sep; 84(9):829-38. PubMed ID: 10477458
    [Abstract] [Full Text] [Related]

  • 5. [Antiphospholipid antibodies: clinical significance and biological diagnosis].
    Arnoux D, Boutière B, Sanmarco M.
    Ann Biol Clin (Paris); 2000 Sep; 58(5):557-74. PubMed ID: 11022099
    [Abstract] [Full Text] [Related]

  • 6. Antiprothrombin and antiannexin V antibodies imply risk of thrombosis in patients with systemic autoimmune diseases.
    Lakos G, Kiss E, Regeczy N, Tarjan P, Soltesz P, Zeher M, Bodolay E, Szucs G, Szakony S, Sipka S, Szegedi G.
    J Rheumatol; 2000 Apr; 27(4):924-9. PubMed ID: 10782817
    [Abstract] [Full Text] [Related]

  • 7. Does the anti-prothrombin antibodies measurement provide additional information in patients with thrombosis?
    Bardin N, Alessi MC, Dignat-George F, Vague IJ, Sampol J, Harlé JR, Sanmarco M.
    Immunobiology; 2007 Apr; 212(7):557-65. PubMed ID: 17678713
    [Abstract] [Full Text] [Related]

  • 8. [Antiphospholipid syndrome and stroke].
    Kitagawa Y.
    Rinsho Shinkeigaku; 2005 Nov; 45(11):852-5. PubMed ID: 16447744
    [Abstract] [Full Text] [Related]

  • 9. Autoantibodies against phosphatidylserine, prothrombin and phosphatidylserine-prothrombin complex: identical or distinct diagnostic tools for antiphospholipid syndrome?
    Jaskowski TD, Wilson AR, Hill HR, Branch WD, Tebo AE.
    Clin Chim Acta; 2009 Dec; 410(1-2):19-24. PubMed ID: 19751711
    [Abstract] [Full Text] [Related]

  • 10. High prevalence of anti-prothrombin antibody in patients with deep vein thrombosis.
    Ishikura K, Wada H, Kamikura Y, Hattori K, Fukuzawa T, Yamada N, Nakamura M, Nobori T, Nakano T.
    Am J Hematol; 2004 Aug; 76(4):338-42. PubMed ID: 15282665
    [Abstract] [Full Text] [Related]

  • 11. Prevalence of antibodies to beta2-glycoprotein I in systemic lupus erythematosus and their association with antiphospholipid antibody syndrome criteria: a single center study and literature review.
    Bruce IN, Clark-Soloninka CA, Spitzer KA, Gladman DD, Urowitz MB, Laskin CA.
    J Rheumatol; 2000 Dec; 27(12):2833-7. PubMed ID: 11128672
    [Abstract] [Full Text] [Related]

  • 12. Identification of thrombin antibodies in patients with antiphospholipid syndrome.
    Miesbach W, Matthias T, Scharrer I.
    Ann N Y Acad Sci; 2005 Jun; 1050():250-6. PubMed ID: 16014540
    [Abstract] [Full Text] [Related]

  • 13. Association of autoantibodies against the phosphatidylserine-prothrombin complex with manifestations of the antiphospholipid syndrome and with the presence of lupus anticoagulant.
    Atsumi T, Ieko M, Bertolaccini ML, Ichikawa K, Tsutsumi A, Matsuura E, Koike T.
    Arthritis Rheum; 2000 Sep; 43(9):1982-93. PubMed ID: 11014348
    [Abstract] [Full Text] [Related]

  • 14. Clinical significance of antiphospholipid protein antibodies. Receiver operating characteristics plot analysis.
    Musial J, Swadzba J, Motyl A, Iwaniec T.
    J Rheumatol; 2003 Apr; 30(4):723-30. PubMed ID: 12672190
    [Abstract] [Full Text] [Related]

  • 15. Autoantibodies to beta2-glycoprotein I in systemic lupus erythematosus and primary antiphospholipid antibody syndrome: clinical correlations in comparison with other antiphospholipid antibody tests.
    Day HM, Thiagarajan P, Ahn C, Reveille JD, Tinker KF, Arnett FC.
    J Rheumatol; 1998 Apr; 25(4):667-74. PubMed ID: 9558167
    [Abstract] [Full Text] [Related]

  • 16. Anti-beta2-glycoprotein I, anti-prothrombin and anticardiolipin antibodies in a longitudinal study of patients with systemic lupus erythematosus and the antiphospholipid syndrome.
    Inanç M, Donohoe S, Ravirajan CT, Radway-Bright EL, Mackie I, Machin S, Isenberg DA.
    Br J Rheumatol; 1998 Oct; 37(10):1089-94. PubMed ID: 9825748
    [Abstract] [Full Text] [Related]

  • 17. High titer of anti-phosphatidylserine-prothrombin complex antibodies in patients with cutaneous polyarteritis nodosa.
    Kawakami T, Yamazaki M, Mizoguchi M, Soma Y.
    Arthritis Rheum; 2007 Dec 15; 57(8):1507-13. PubMed ID: 18050170
    [Abstract] [Full Text] [Related]

  • 18. The presence of anti-phosphatidylserine/prothrombin antibodies as risk factor for both arterial and venous thrombosis in patients with systemic lupus erythematosus.
    Nojima J, Iwatani Y, Suehisa E, Kuratsune H, Kanakura Y.
    Haematologica; 2006 May 15; 91(5):699-702. PubMed ID: 16627257
    [Abstract] [Full Text] [Related]

  • 19. Antiprothrombin antibody: why do we need more assays?
    Atsumi T, Koike T.
    Lupus; 2010 Apr 15; 19(4):436-9. PubMed ID: 20353984
    [Abstract] [Full Text] [Related]

  • 20. [Following 90 patients with antiphospholipid syndrome with antibody titers and correlations with clinical manifestations: symptoms of the disease, a new antibody and correlations with clinical manifestations in the Israeli population].
    Marai I, Levi Y, Godard G, Shoenfeld Y.
    Harefuah; 2001 Jun 15; 140(6):495-500, 565. PubMed ID: 11420848
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 169.